To see if you qualify for one of our personalized prescription weight loss medications, we encourage you to take our free assessment quiz
Model evaluation Individual predictions vs
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) commonly studied for its interaction with pituitary signaling pathways and endocrine communication systems
Gellmans company Longevity Biotech now has a drug candidate that activates both GLP-1 and GIP, is biased towards the insulin signalling pathway and can be orally formulated
Members who qualify have access to weight-loss medications, including the latest GLP-1s, for much less than the list price even without insurance coverage
While the cost may be higher compared to a gym membership or diet plans, the value lies in the effectiveness, medical support, and lasting results these treatments provide